Company News: BellaSeno’s Senella® Medical Implant Technology Named a Bronze Winner of the 2020 Edison Awards

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that its Senella®  implant technology has won a Bronze Edison Award 2020 in the category Medical / Dental, subcategory Medical Implants.

Read more…

Company News: Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

– Rapid real-time PCR test allows testing for SARS-CoV2 in only a few hours
– Test kit to be made available via Curetis’ European sales channels
– Synergies with Curetis Unyvero HPN panel for pneumonia testing for bacterial co-infections in Covid-19 patients

Curetis N.V. (the “Company” and together with its subsidiaries “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that it starts offering a CE-IVD certified real-time PCR test kit for SARS-CoV2 (also known as 2019-nCov), the causal pathogen of Corona Virus Disease 2019 (Covid-19).

Read more…

Food for Thought: Communication in the time of Covid-19

Communication in the time of Covid-19

Part 1: Go digital, remain visible

Both trade and general media are predominantly occupied with coverage of the new Coronavirus epidemic: diagnostics, potential therapies, consequences for the healthcare system, for funding/investments as well as logistics, given that supply of chemicals and medical goods from China is declining rapidly.

Read more…

Company News: Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update

— Revenue increases by 64% to EUR 2.3 million, up from 1.4 million in 2018

— More than tripled total contract order volume received year-over-year to about EUR 3.4 million 2019

— Curetis N.V. shareholders to vote on March 10, 2020 on planned business combination with OpGen, Inc.

Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced preliminary. unaudited condensed combined key financials for the fiscal year 2019 and provided a business update for 2020 year-to-date.

Read more…

1 2 3 150